Skip to main content
Premium Trial:

Request an Annual Quote

Cold Spring Harbor Laboratory Joins Illumina Genome Network

NEW YORK (GenomeWeb News) – Cold Spring Harbor Laboratory has joined the Illumina Genome Network, Illumina announced today.

Richard McCombie, a professor at CSHL, said in a statement that his organization seeks to improve the diagnosis and treatment of cancer, neurological disorders, and other diseases, and "by participating in IGN, we are enriching the capabilities of researchers as they strive to solve biology's most challenging problems."

Christian Henry, Illumina's senior vice president and GM of the genomic solutions business, added, "Through the Illumina Genome Network, we believe we can speed discovery in areas where CSHL excels, including approaches to understanding tumor development, progression, and therapeutic response."

Other members in the IGN that provide a full range of whole-genome sequencing services include the Broad Institute; the British Columbia Cancer Agency; the University of Washington Department of Genome Sciences; the National Center for Genome Resources; Macrogen and Genomic Medicine Institute in Seoul, South Korea; and Illumina's FastTrack Services lab in San Diego.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.